Geratherm Medical AG

Earnings Release • May 13, 2009

News Details

Ad-hoc | 13 May 2009 13:36

Geratherm Medical AG: preliminary business figures Q I/2009

Geratherm Medical AG / Preliminary Results

Release of an Ad hoc announcement according to § 15 WpHG, transmitted by
DGAP - a company of EquityStory AG.
The issuer is solely responsible for the content of this announcement.

---

DGAP-Adhoc: Geratherm Medical AG - preliminary business figures Q I/2009

Ad-hoc announcement pursuant to Section 15 WpHG (German Securities Trading
Act) transmitted by DGAP - a company of the Equity Story AG. The issuer is
responsible for the contents of this announcement.

* Turnover EUR 3.1 million +35 %

* EBITDA kEUR 575 +199 %

* EBITDA margin 18.5 % (p.y.: 8.3 %)

* EBIT kEUR 500 +332 %

* Earnings per share 2 cents (p.y.: 3 cents)

Geschwenda, 13th May 2009 - Leap in turnover and earnings of Geratherm
Medical in the first quarter of 2009. Impulses for growth through
introduction of innovative products and EU ban on mercury as of 3 April
2009. The positive development of the company will continue throughout the
next quarters.

Publication of the detailed quarterly figures is scheduled for 20 May 2009.

Profil:

Geratherm Medical is an internationally operating medical products
enterprise with the business areas Health Care Diagnostik, Medical Warming
Systems, Cardio/Stroke and Respiratory.

Our company's roots are in temperature measurement in the medical sphere.
In this business area we offer a broad spectrum of products, most of which
have unique selling points. We supply our customers/patients with
high-quality products ranging from thermometers to complex warming systems
for use in the operating theatre and by emergency rescue services. In the
Cardio business area we concentrate on the development of products for the
detection of atrial fibrillation as a measure to prevent strokes. The
Respiratory segment develops and markets products for the assessment of
pulmonary function.

In all three business areas, Geratherm has patent-protected basic
technologies at its disposal. We regard ourselves as a research-based
medical products company with a clear focus on medical diagnostic devices
that generate vital data.

Geratherm shares have been listed in the Prime Standard segment of the
Frankfurt Stock Exchange since the year 2000. Geratherm Medical continues
to be represented in the German Entrepreneurial Index and in the German
Health-Care Index.

Geratherm Medical AG, Investor Relations

Fahrenheitstraße 1, 98716 Geschwenda

Tel. +49 (0)36205/98 111, E-Mail: info@geratherm.com www.geratherm.com

Emittent: Geratherm Medical AG, Fahrenheitstraße 1, 98716 Geschwenda
Deutschland

Tel. 036205/98 111 Fax: 036205/98 115

ISIN : DE 000 549 562 6

WKN : 549 562

Börsen : Frankfurter Wertpapierbörse /Geregelter Markt/Prime Standard

Börse: Freiverkehr in Berlin-Bremen, Düsseldorf, Hamburg, München,
Stuttgart

• Ende der Mitteilung -
  13.05.2009 Financial News transmitted by DGAP

---

Language: English
Issuer: Geratherm Medical AG
Fahrenheitstraße 1
98716 Geschwenda
Deutschland
Phone: +49 (0)36205 98-0
Fax: +49 (0)36205 98-1 15
E-mail: info@geratherm.com
Internet: www.geratherm.com
ISIN: DE0005495626
WKN: 549562
Listed: Regulierter Markt in Frankfurt (Prime Standard); Freiverkehr
in Berlin, Düsseldorf, Hamburg, München, Stuttgart

End of News DGAP News-Service

---